Pharma-Bio Serv
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pharma-Bio Serv generated cash of $1,890,960, which is more than the previous year. Cash used in financing activities reached the amount of -$1,758,163 last year. Net change in cash is therefore -$4,016,675.
Cash Flow
| 2014 | 3.33M | -168.70K | -91.26K |
|---|---|---|---|
| 2015 | 372.60K | -342.36K | -190.72K |
| 2016 | 709.65K | -1.77M | -68.70K |
| 2017 | -1.54M | -403.94K | -71.10K |
| 2018 | 3.71M | -116.00K | -1.79M |
| 2019 | -2.20M | 1.83M | -155.57K |
| 2020 | 1.52M | -28.95K | 193.67K |
| 2021 | 804.84K | 1.29M | -1.75M |
| 2022 | 592.45K | -19.26K | -3.52M |
| 2023 | 1.89M | -4.21M | -1.75M |
PBSV Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.46M | 17.46M | 17.13M | 15.49M | 16.02M | 11.59M | 13.77M | 14.89M | 15.08M | 12.04M |
Operating activities | ||||||||||
Net income | 1.31M | 1.00M | -2.08M | 2.05M | 2.08M | -1.26M | -1.41M | -256.57K | 1.62M | 2.41M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 194.32K | 51.10K | 72.72K | 86.28K | 99.09K | 74.60K | 443.99K | 312.55K | 357.46K | 377.19K |
Stock-based compensation expense | 45.08K | 71.64K | 56.23K | 42.87K | 34.12K | 51.64K | 63.87K | 88.88K | 87.11K | 94.4K |
| Deferred income tax benefit | 45.08K | 71.64K | 56.23K | 42.87K | 34.12K | 51.64K | 63.87K | 88.88K | 87.11K | 94.4K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.09M | -463.32K | -134.99K | -944.25K | -3.59M | 1.15M | -18.99K | 647.28K | -1.06M | 1.05M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 1.89M | 592.45K | 804.84K | 1.52M | -2.20M | 3.71M | -1.54M | 709.65K | 372.60K | 3.33M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -99.03K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -7.25K | -19.26K | -10.84K | -55.65K | -57.37K | -122.00K | -451.70K | -1.80M | -342.36K | -207.50K |
Acquisitions Net | 0 | 0 | 57.57K | 26.7K | 99.03K | 6K | 47.75K | 29.62K | 0 | 0 |
Cash generated by investing activities | -4.21M | -19.26K | 1.29M | -28.95K | 1.83M | -116.00K | -403.94K | -1.77M | -342.36K | -168.70K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30M |
Payments for dividends | -1.72M | -3.44M | -1.72M | -1.72M | 0 | -1.72M | 0 | 0 | 0 | 0 |
Repurchases of common stock | -34.34K | -81.99K | -25.96K | -1.69K | -87.89K | -56.52K | -15.42K | -45.91K | -168.73K | -18.08K |
Repayments of term debt | 0 | 0 | 0 | -11.03K | -67.68K | -13.94K | -55.67K | -22.78K | -21.99K | -73.17K |
Cash used in financing activities | -1.75M | -3.52M | -1.75M | 193.67K | -155.57K | -1.79M | -71.10K | -68.70K | -190.72K | -91.26K |
Net Change In Cash | -4.01M | -3.00M | 330.42K | 1.64M | -539.74K | 4.43M | -2.02M | -1.11M | -194.68K | 3.04M |
Cash at end of period | 10.44M | 14.46M | 17.46M | 17.13M | 15.49M | 16.02M | 11.75M | 13.77M | 14.89M | 15.08M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |